Surgical wounds are projected to increase in number at an annual rate of 3%, but overall the severity and size of surgical wounds will continue to decrease over the next five years as a result of the continuing trend toward minimally invasive surgery.
Surgical procedures generate a large number of uncomplicated acute wounds with uneventful healing, and a lower number of chronic wounds such as those generated by wound dehiscence or post-operative infection. On the skin surface, surgical wounds most often are closed by “primary intent,” i.e., using products such as sutures, staples, or glues, where the two sides across the incision line are brought close and mechanically held together. The use of glues for closure has rapidly become adopted for treatment of minor cuts and grazes over the last decade and products in this category are now being promoted for use in the operating room, where they offer certain advantages over sutures. Benefits for use on the skin surface include reduced need for anesthesia, reduced infection, and reduced scarring.
A growing number of wounds created as part of the surgical procedure are becoming infected by pathogens that exhibit some resistance to antibiotics. Recent figures indicate that, on average, 8% of wounds are infected in the hospital during surgical procedures. Adjunctive surgical closure and securement products have been shown to reduce infection levels. As such, cyanoacrylate adhesives have been approved in the United States to help prevent post-surgical infections (among other functions).
Surgical hemostats, tissue sealants, and glues are used for a spectrum of surgical procedures ranging from closure of skin wounds to significant hemostasis and to prevent blood replacement during major surgical procedures.
Source: Report #S175, "Worldwide Surgical Sealants, Glues and Wound Closure, 2009-2013."